CSL LtdOTCQX International:CSLLY
No Matches were found for
- LAST PRICE98.7900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 98.7900
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Select an index
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CSLLY |
|---|---|---|
| 09:32 ET | 461 | 97.24 |
| 09:48 ET | 500 | 98.58 |
| 10:01 ET | 102 | 99.08 |
| 10:03 ET | 244 | 98.8395 |
| 10:14 ET | 268 | 98.865 |
| 10:17 ET | 119 | 98.935 |
| 10:33 ET | 200 | 98.79 |
| 10:44 ET | 200 | 98.92 |
| 10:50 ET | 129 | 98.86 |
| 11:04 ET | 164 | 98.86 |
| 11:06 ET | 292 | 98.85 |
| 11:08 ET | 788 | 98.84 |
| 11:36 ET | 100 | 98.74 |
| 11:58 ET | 378 | 98.67 |
| 12:07 ET | 1485 | 98.655 |
| 12:20 ET | 342 | 98.6515 |
| 01:15 ET | 316 | 98.797 |
| 01:55 ET | 358 | 98.775 |
| 02:04 ET | 400 | 98.71 |
| 02:06 ET | 1171 | 98.788 |
| 02:09 ET | 200 | 98.72 |
| 02:11 ET | 446 | 98.708 |
| 02:13 ET | 800 | 98.67 |
| 02:24 ET | 264 | 98.35 |
| 02:29 ET | 400 | 98.2 |
| 02:56 ET | 101 | 98.474 |
| 03:12 ET | 778 | 98.46 |
| 03:20 ET | 541 | 98.35 |
| 03:21 ET | 169 | 98.406 |
| 03:32 ET | 374 | 98.43 |
| 03:43 ET | 225 | 98.4925 |
| 03:52 ET | 157 | 98.47 |
| 03:59 ET | 105 | 98.79 |
Yesterday
Sep 25, 2024
CSL Seqirus, a Global Leader in Pandemic Preparedness, Announces Fifth BARDA Award in Response to Avian Influenza Outbreak, from 4:30PM ET on Wednesday Sep 25, 2024 by Dow Jones
4:30PM ET on Wednesday Sep 25, 2024 by Dow Jones
Sep 24, 2024
Veltassa(R) (patiromer) approved in Japan for the treatment of adults with hyperkalemia, from 3:30AM ET on Tuesday Sep 24, 2024 by Dow Jones
3:30AM ET on Tuesday Sep 24, 2024 by Dow Jones
Sep 13, 2024
Japan's Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics' Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma, from 8:00AM ET on Friday Sep 13, 2024 by Dow Jones
8:00AM ET on Friday Sep 13, 2024 by Dow Jones
Sep 12, 2024
DJ CSL Competitor Moderna Shifts Flu Vaccine Strategy -- Market Talk, from 8:08PM ET on Thursday Sep 12, 2024 by Dow Jones
8:08PM ET on Thursday Sep 12, 2024 by Dow Jones
Company Information
No data available
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | --- |
|---|---|
Revenue (TTM) | --- |
Shares Outstanding | --- |
Dividend Yield | 1.20% |
Annual Dividend Rate | 1.1900 USD |
Ex-Dividend Date | 03-11-24 |
Pay Date | 04-10-24 |
Beta | --- |
EPS | --- |
Book Value | --- |
P/E Ratio | --- |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
